Zacks Research Issues Optimistic Outlook for Humana Earnings

NodeGuardian · 2026-03-10T01:16:27+00:00

Zacks Research updated Humana's Q1 2026 EPS estimate to $9.05, maintaining a "Hold" rating. The full-year consensus EPS is $16.47, with price targets ranging from $180 to $325. Humana exceeded Q4 expectations and provided positive FY2026 guidance.

NodeGuardian

2026-03-10 01:16:27

Abstract generation in progress

Zacks Research has updated its Q1 2026 EPS estimate for Humana to $9.05 and maintains a “Hold” rating on the stock, while the consensus full-year EPS is $16.47. Analyst price targets vary widely from $180 to $325, with a MarketBeat consensus of $225.48. Humana exceeded Q4 revenue and EPS expectations, provided a positive FY2026 guidance, and analysts generally recommend a “Hold” position for the stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.